Health OSdemo workspace
Employer

Silverline Foodsactive

Internal only · as of Oct 14
Period member reach
83%
20 distinct people76.9% long-term
Jul 2026 reach
31%
8 of 26 covered+4 pp vs Jun 2026
Care delivered
96
10.7 visits / month20 people
Preventive share
28%
27 preventive visits46% acute
Known risk signal
29%
10 of 35 adults3 higher severity
Reporting periodNov 2025 – Jul 20269 months
Change period
Visits through Jul 31, 2026 · measures through Jul 28, 2026

Population

covered lives and relationship mix
Covered lives by month
30022Nov '2523Dec '2523Jan '2624Feb '2624Mar '2625Apr '2625May '2626Jun '2626Jul '26
employeesspouses and children
Jul 2026 mix26 covered lives
Employees25 96%
Spouses1 4%
Children0 0%
Care delivered
Monthly member reach
35%0%Nov 2025: 23% reach · 5 of 22 covered lives seenNov '25Dec 2025: 26% reach · 6 of 23 covered lives seenDec '25Jan 2026: 30% reach · 7 of 23 covered lives seenJan '26Feb 2026: 29% reach · 7 of 24 covered lives seenFeb '26Mar 2026: 33% reach · 8 of 24 covered lives seenMar '26Apr 2026: 32% reach · 8 of 25 covered lives seenApr '26May 2026: 28% reach · 7 of 25 covered lives seenMay '26Jun 2026: 27% reach · 7 of 26 covered lives seenJun '26Jul 2026: 31% reach · 8 of 26 covered lives seenJul '2623%26%30%29%33%32%28%27%31%
member reach · people seen ÷ covered lives that month
Clinical activityvisit-type evidence · 96 visits
Preventive27 28%
Acute44 46%
Health review18 19%
Other7 7%
Delivery87 in person9 virtual

Clinical risk burden

Known clinical signals across the covered adult population.

35 adults

Population burden

40 dots · Each ≈ 2.5% of covered adults

Higher severity
3 8.6%
Included in elevated signal
Elevated signal
10 28.6%
Moderate + higher severity
Assessed
24 68.6%
Adults with scoreable evidence
Unknown
11 31.4%
Includes unmeasured results
Higher severityModerateNo elevated signal observedUnknown / unmeasured
Risk by clinical domainThrough Jul 31, 2026 · 24-month lookback
Ranked by higher-severity count

Metabolic

24 of 35 assessed · 68.6% coverage

28.6% moderate or higher

10 adults · 3 higher severity

Higher severity
8.6%
Moderate
20%
No elevation
40%
Unknown
31.4%

All percentages use covered adults. Population burden counts each adult once; clinical domains overlap. No elevation means no elevated signal observed.

Risk concentrationAdults by number of known affected clinical domains
Known burden; no minimum-evidence gate
Unknown11 31%
0 known affected domains14 40%
1 affected domain10 29%
2 affected domains0 0%
3+ affected domains0 0%
Common overlapping domainsAdults with known elevated evidence in both domains

No multi-domain overlap is visible in current scoreable evidence.

Core indicator detailSingle-measure context; not complete clinical domains
Blood pressureSystolic proxy · 124 mmHg avg40% 14 of 35
Weight / metabolicBMI proxy · 27.1 kg/m² avg37% 13 of 35
Glycemic / insulinA1C proxy · 5.8% avg23% 8 of 35
Lipid / vascularLDL proxy · 119.0 mg/dL avg29% 10 of 35

Risk uses each marker’s latest scoreable result on or before the report end date, up to 24 months old. Unit-missing values never enter numeric model bands; exact source high/low flags contribute a moderate known signal. Any known elevated result counts immediately; missing evidence remains unknown.

Monthly detail

the underlying ledger
MonthCovered livesemployees · spouses · childrenJoined / leftVisitsPeople seenMember reachPreventiveAcuteHealth reviewOtherIn personVirtual
Nov 20252221 · 1 · 0+1 −08523%242071
Dec 20252322 · 1 · 0+1 −09626%242181
Jan 20262322 · 1 · 0+0 −011730%3521101
Feb 20262423 · 1 · 0+1 −010729%342191
Mar 20262423 · 1 · 0+0 −012833%3621111
Apr 20262524 · 1 · 0+1 −013832%4621121
May 20262524 · 1 · 0+0 −011728%3521101
Jun 20262625 · 1 · 0+1 −010727%352091
Jul 20262625 · 1 · 0+0 −112831%4521111
Period24monthly average · 22–26+5 −19620distinct83%of 24.2 average enrollment2744187879
9 of 9 months contain observed encounters